Sarah Glorioso, M.D.
NPI 1093916140 · Dermatology Physician · Bossier City, LA
Enrolled with Medicare as Practitioner - Dermatology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Sarah Glorioso, M.D. is a Dermatology Physician provider in Bossier City, LA (NPI 1093916140).
Provider details
- NPI number
- 1093916140
- Entity type
- Individual
- Primary specialty
- Dermatology PhysicianAllopathic & Osteopathic Physicians
- Credential
- M.D.
- Sex
- Female
- Sole proprietor
- No
- License
- MD.201108 (LA)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
19 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
12,352 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Destruction of Precancer Skin Growth, 2-14 Growths17003 | 6,628 | $6 |
| Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213 | 1,601 | $86 |
| Destruction of Precancer Skin Growth, 1 Growth17000 | 1,251 | $51 |
| Destruction of Skin Growth, 1-14 Growths17110 | 568 | $103 |
| Biopsy of Related Skin Growth, First Growth11102 | 517 | $82 |
| Destruction of Precancer Skin Growth, 15 Or More Growths17004 |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 33 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Ketoconazole | 253 | 140 |
| Triamcinolone Acetonide | 247 | 170 |
| Clobetasol Propionate | 200 | 106 |
| Mupirocin | 193 | 141 |
| Fluocinonide | 90 | 58 |
| Hydrocortisone | 75 | 57 |
| Doxycycline Hyclate | 69 | 51 |
| Fluorouracil | 63 | 56 |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$1,170 across 53 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2007-05-29
- Last updated
- 2021-07-14
- Certified
- 2021-07-14
Frequently asked questions
- What is Sarah Glorioso's NPI number?
- Sarah Glorioso's National Provider Identifier (NPI) is 1093916140, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
- What is Sarah Glorioso's specialty?
- Sarah Glorioso is listed in the NPPES registry with a primary specialty of Dermatology Physician (Allopathic & Osteopathic Physicians).
- Where is Sarah Glorioso located?
- Sarah Glorioso's practice location on file with NPPES is 2300 Hospital Dr., Bossier City, LA 71111-2180.
- What is Sarah Glorioso's phone number?
- The practice phone number listed in the NPPES registry for Sarah Glorioso is (318) 212-7800.
- Does Sarah Glorioso accept Medicare?
- Sarah Glorioso is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
- Is Sarah Glorioso's NPI active?
- Yes — Sarah Glorioso's NPI (1093916140) is active in the NPPES registry as of the last update on 2021-07-14.
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.